Five-Year Outcome of Cholinergic Treatment of Alzheimer’s Disease: Early Response Predicts Prolonged Time until Nursing Home Placement, but Does Not Alter Life Expectancy

Publisher： Karger

E-ISSN： 1421-9824|18|2|197-206

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.18, Iss.2, 2004-08, pp. : 197-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Donepezil Treatment of Severe Alzheimer’s Disease in Nursing Home Settings. A Responder Analysis

By  

Dementia and Geriatric Cognitive Disorders, Vol. 26, Iss. 5, 2008-11 ,pp. : 458-466

Karger

Access to resources Recommend Favorite

Two-Year Treatment of Alzheimer’s Disease with Eptastigmine

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 2, 1999-02 ,pp. : 139-147

Karger

Access to resources Recommend Favorite

Atrophy of the Substantia innominata on Magnetic Resonance Imaging Predicts Response to Donepezil Treatment in Alzheimer’s Disease Patients

By  

Dementia and Geriatric Cognitive Disorders, Vol. 16, Iss. 3, 2003-07 ,pp. : 119-125

Karger

Access to resources Recommend Favorite

Treatment of Delusions in Alzheimer’s Disease – Response to Pharmacotherapy

By  

Dementia and Geriatric Cognitive Disorders, Vol. 22, Iss. 3, 2006-08 ,pp. : 260-266

Karger

Access to resources Recommend Favorite

Galantamine Prolonged-Release Formulation in the Treatment of Mild to Moderate Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 20, Iss. 2-3, 2005-08 ,pp. : 120-132

Karger

Access to resources Recommend Favorite